<DOC>
	<DOCNO>NCT02770261</DOCNO>
	<brief_summary>The purpose study determine superiority DP-R208 compare monotherapy patient hypertension primary hypercholesterolemia .</brief_summary>
	<brief_title>Phase III Clinical Trial Evaluate Efficacy Safety DP-R208 Each Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Both man woman 19years old . Hypertension primary cholesterolemia satisfy lab result Mean msSBP 180mmHg Mean msDBP 110mmHg LDLC 250mg/DL Triglycerides 400mg/dL Therapeutic lifestylechange enought study period SBP difference big 20mmHg DBP difference big 10mmHg screen visit</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>DP-R208</keyword>
</DOC>